Literature DB >> 22251552

Quinolinic acid: neurotoxicity.

Gilles J Guillemin1.   

Abstract

This minireview series reviews some of the most recent findings about quinolinic acid's cellular toxicity and its implications in diseases such as HIV associated neurocognitive disorders, depressive disorders and schizophrenia, and finally therapeutic strategies with drugs able to interfere with quinolinic acid production and/or effects.
© 2012 The Author Journal compilation © 2012 FEBS.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22251552     DOI： 10.1111/j.1742-4658.2012.08493.x

Source DB:  PubMed          Journal:  FEBS J        ISSN： 1742-464X            Impact factor:   5.542


  26 in total

1.  Tryptophan catabolism and vitamin B-6 status are affected by gender and lifestyle factors in healthy young adults.

Authors:  Oana M Deac; James L Mills; Barry Shane; Øivind Midttun; Per M Ueland; John T Brosnan; Margaret E Brosnan; Eamon Laird; Eileen R Gibney; Ruzong Fan; Yifan Wang; Lawrence C Brody; Anne M Molloy
Journal:  J Nutr       Date:  2015-02-18       Impact factor: 4.798

2.  Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

Authors:  M K Larsson; A Faka; M Bhat; S Imbeault; M Goiny; F Orhan; A Oliveros; S Ståhl; X C Liu; D S Choi; K Sandberg; G Engberg; L Schwieler; S Erhardt
Journal:  Neurochem Res       Date:  2016-05-10       Impact factor: 3.996

3.  Maternal Inflammation Results in Altered Tryptophan Metabolism in Rabbit Placenta and Fetal Brain.

Authors:  Monica Williams; Zhi Zhang; Elizabeth Nance; Julia L Drewes; Wojciech G Lesniak; Sarabdeep Singh; Diane C Chugani; Kannan Rangaramanujam; David R Graham; Sujatha Kannan
Journal:  Dev Neurosci       Date:  2017-05-11       Impact factor: 2.984

Review 4.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

5.  Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway.

Authors:  Yahya Jand; Mohammad Hossein Ghahremani; Amir Ghanbari; Shahram Ejtemaei-Mehr; Gilles J Guillemin; Mahmoud Ghazi-Khansari
Journal:  Sci Rep       Date:  2022-09-24       Impact factor: 4.996

6.  Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons.

Authors:  Nady Braidy; Bruce J Brew; Nibaldo C Inestrosa; Roger Chung; Perminder Sachdev; Gilles J Guillemin
Journal:  Metab Brain Dis       Date:  2014-05-16       Impact factor: 3.584

Review 7.  Kynurenine pathway metabolites and suicidality.

Authors:  Elena Y Bryleva; Lena Brundin
Journal:  Neuropharmacology       Date:  2016-01-26       Impact factor: 5.250

8.  Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.

Authors:  Edwin B Yan; Tony Frugier; Chai K Lim; Benjamin Heng; Gayathri Sundaram; May Tan; Jeffrey V Rosenfeld; David W Walker; Gilles J Guillemin; Maria Cristina Morganti-Kossmann
Journal:  J Neuroinflammation       Date:  2015-05-30       Impact factor: 8.322

Review 9.  NAD+ Metabolism, Metabolic Stress, and Infection.

Authors:  Benjamin Groth; Padmaja Venkatakrishnan; Su-Ju Lin
Journal:  Front Mol Biosci       Date:  2021-05-19

10.  Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial.

Authors:  Vincent Millischer; Matthias Heinzl; Anthi Faka; Michael Resl; Ada Trepci; Carmen Klammer; Margot Egger; Benjamin Dieplinger; Martin Clodi; Lilly Schwieler
Journal:  J Neuroinflammation       Date:  2021-07-17       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.